Automated Sperm Sample Preparation Protocol
Launched by NANONC INC. · Jun 26, 2019
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
Nanonc proposes an automated system for sperm sample preparation that will take in raw ejaculate and output a purified sperm population in an IUI syringe in less than 15 minutes. The IUI syringe will be detachable from the rest of the system. During the 15 minutes, the clinician will not need to perform any actions; as the system will run all of the sample processing steps in an automated fashion. Furthermore, the system will have a footprint of a small desktop printer that is portable to be conveniently placed on a bench in clinical setting. A portable system that performs automated isolat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any couple with doctor's order for IUI with density gradient centrifugation
- Exclusion Criteria:
- • Azoospermia
About Nanonc Inc.
Nanonc Inc. is a pioneering biotechnology company focused on advancing innovative therapies for the treatment of cancer through the development of targeted nanomedicine solutions. Leveraging cutting-edge nanotechnology, the company aims to enhance the precision and efficacy of cancer treatments while minimizing systemic side effects. With a commitment to scientific excellence and patient-centric approaches, Nanonc Inc. is dedicated to transforming cancer care and improving outcomes for patients by conducting rigorous clinical trials that validate the safety and effectiveness of its novel therapeutic candidates.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Raheel Samuel, PhD
Principal Investigator
Nanonc Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials